DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Maternal And Infant Antipsychotic Study

Recruiting

Conditions: Pregnancy
Antipsychotics

Interventions: Drug: Non-antipsychotic medication
Other: No Medication
Drug: Antipsychotics

First Posted Date: 2023-09-22

Last Posted Date: 2024-08-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 200

Registration Number: NCT06049953

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Phase 1

Recruiting

Conditions: Ovarian Cancer
Malignant Neoplasm of Uterus

Interventions: Drug: Sacituzumab
Drug: Cisplatin

First Posted Date: 2023-09-18

Last Posted Date: 2024-10-31

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 54

Registration Number: NCT06040970

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York, New York, United States

CTSN Embolic Protection Trial

Not Applicable

Recruiting

Conditions: Ischemic Stroke
Delirium
Acute Kidney Injury
Heart Valve Disease
Coronary Artery Disease

Interventions: Device: CardioGard Embolic Protection Cannula
Device: Standard Aortic Cannula

First Posted Date: 2023-09-07

Last Posted Date: 2025-03-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 842

Registration Number: NCT06027788

Locations: 🇺🇸
CHI St. Vincent Heart Institute, North Little Rock, Arkansas, United States
🇺🇸
Keck Hospital of the University of Southern California, Los Angeles, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 25 locations

PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea

Phase 2

Terminated

Conditions: Seborrheic Dermatitis
Papulopustular Rosacea

Interventions: Drug: Placebo Ointment
Drug: PF-07038124

First Posted Date: 2023-08-28

Last Posted Date: 2025-04-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 32

Registration Number: NCT06013371

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

Recruiting

Conditions: Crohns Disease
Inflammatory Bowel Disease
Pregnancy

First Posted Date: 2023-08-21

Last Posted Date: 2024-10-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 42

Registration Number: NCT06001450

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Changes in Inhibition and Valuation After Eating

Not Applicable

Recruiting

Conditions: Bulimia Nervosa

Interventions: Other: Fasting state
Other: Fed state
Other: Magnetic Resonance Imaging

First Posted Date: 2023-08-16

Last Posted Date: 2025-01-30

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 150

Registration Number: NCT05995496

Locations: 🇺🇸
Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai, New York, New York, United States

Rosuvastatin and Evolocumab for Coronary Artery Disease

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: statin
Drug: evolocumab

First Posted Date: 2023-08-09

Last Posted Date: 2023-08-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 195

Registration Number: NCT05984953

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

Recruiting

Conditions: Multiple Sclerosis
Demyelinating Autoimmune Diseases, CNS
Neuromyelitis Optica

First Posted Date: 2023-08-09

Last Posted Date: 2024-07-01

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 100

Registration Number: NCT05982925

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

Targeting Drug Memories With Methylphenidate

Early Phase 1

Recruiting

Conditions: Substance Use Disorder
Cocaine Use Disorder

Interventions: Drug: Methylphenidate
Behavioral: Memory reconsolidation
Drug: Placebo

First Posted Date: 2023-08-07

Last Posted Date: 2024-06-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 50

Registration Number: NCT05978167

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis

Not Applicable

Recruiting

Conditions: Clinical High Risk for Psychosis (CHR)

Interventions: Behavioral: Individual CBT sessions
Behavioral: CBT Skills Group for CHR Youth
Behavioral: CBT Skills Group for Families

First Posted Date: 2023-08-01

Last Posted Date: 2024-06-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 72

Registration Number: NCT05968560

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy